Related references
Note: Only part of the references are listed.The anti-apoptotic members of the Bcl-2 family are attractive tumor-associated antigens
Oncotarget (2015)
BMI1, Stem Cell Factor Acting as Novel Serum-biomarker for Caucasian and African-American Prostate Cancer
Hifzur Rahman Siddique et al.
PLOS ONE (2013)
Molecular Pathways: Regulation and Therapeutic Implications of Multidrug Resistance
Kevin G. Chen et al.
CLINICAL CANCER RESEARCH (2012)
Androgen Receptor in Human Health: A Potential Therapeutic Target
Hifzur Rahman Siddique et al.
CURRENT DRUG TARGETS (2012)
Epicatechin-rich cocoa polyphenol inhibits Kras-activated pancreatic ductal carcinoma cell growth in vitro and in a mouse model
Hifzur Rahman Siddique et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Tumorspheres derived from prostate cancer cells possess chemoresistant and cancer stem cell properties
Linlin Zhang et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2012)
Role of BMI1, a Stem Cell Factor, in Cancer Recurrence and Chemoresistance: Preclinical and Clinical Evidences
Hifzur Rahman Siddique et al.
STEM CELLS (2012)
Global Cancer Statistics
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2011)
Expression Patterns of Bmi-1 and p16 Significantly Correlate With Overall, Disease-Specific, and Recurrence-Free Survival in Oropharyngeal Squamous Cell Carcinoma
Gerhard F. Huber et al.
CANCER (2011)
Lupeol, a Novel Androgen Receptor Inhibitor: Implications in Prostate Cancer Therapy
Hifzur Rahman Siddique et al.
CLINICAL CANCER RESEARCH (2011)
Pathways of chemotherapy resistance in castration-resistant prostate cancer
Kate L. Mahon et al.
ENDOCRINE-RELATED CANCER (2011)
BMI1 silencing enhances docetaxel activity and impairs antioxidant response in prostate cancer
Francesco Crea et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Characterisation and manipulation of docetaxel resistant prostate cancer cell lines
Amanda J. O'Neill et al.
MOLECULAR CANCER (2011)
Enhancing Chemotherapy Response with Bmi-1 Silencing in Ovarian Cancer
Enfeng Wang et al.
PLOS ONE (2011)
Chemotherapy Sensitivity Recovery of Prostate Cancer Cells by Functional Inhibition and Knock Down of Multidrug Resistance Proteins
Catherine Sanchez et al.
PROSTATE (2011)
The Wnt/β-catenin pathway regulates growth and maintenance of colonospheres
Shailender S. Kanwar et al.
MOLECULAR CANCER (2010)
Chronological expression of Wnt target genes Ccnd1, Myc, Cdkn1a, Tfrc, Plf1 and Ramp3
Sonja Roehrs et al.
CELL BIOLOGY INTERNATIONAL (2009)
Bcl-2 Inhibitors: Targeting Mitochondrial Apoptotic Pathways in Cancer Therapy
Min H. Kang et al.
CLINICAL CANCER RESEARCH (2009)
Control of mitochondrial apoptosis by the Bcl-2 family
Joslyn K. Brunelle et al.
JOURNAL OF CELL SCIENCE (2009)
The polycomb group protein Bmi-1 represses the tumor suppressor PTEN and induces epithelial-mesenchymal transition in human nasopharyngeal epithelial cells
Li-Bing Song et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Hedgehog-Gli Signaling Pathway Inhibitors as Anticancer Agents
Neeraj Mahindroo et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
A phase 2 study of carboplatin plus docetaxel in men with metastatic hormone-refractory prostate cancer who are refractory to docetaxel
Robert W. Ross et al.
CANCER (2008)
Targeting of sonic hedgehog-GLI signaling: a potential strategy to improve therapy for mantle cell lymphoma
Ganapati V. Hegde et al.
MOLECULAR CANCER THERAPEUTICS (2008)
ErbB-2 induces the Cyclin D1 gene in prostate epithelial cells in vitro and in vivo
Mathew Casimiro et al.
CANCER RESEARCH (2007)
Elevated Bmi-1 expression is associated with dysplastic cell transformation during oral carcinogenesis and is required for cancer cell replication and survival
M. K. Kang et al.
BRITISH JOURNAL OF CANCER (2007)
Bmi-1 is essential for the tumorigenicity of neuroblastoma cells
Hongjuan Cui et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells
Suling Liu et al.
CANCER RESEARCH (2006)
A novel biomarker for staging human prostate adenocarcinoma: Overexpression of matriptase with concomitant loss of its inhibitor, hepatocyte growth factor activator inhibitor-1
M Saleem et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2006)
Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer
GV Glinsky et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Drug insight: use of docetaxel in prostate and urothelial cancers
NJ Mackler et al.
NATURE CLINICAL PRACTICE UROLOGY (2005)
Transcriptional regulation of bcl-2 mediated by the sonic hedgehog signaling pathway through gli-1
RLH Bigelow et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer
M Han et al.
JOURNAL OF UROLOGY (2003)
Share Paper
